A resurgent bioscience sector pulls Europe into recovery, while U.S. biotech leaders train the next generation of an essential skilled workforce. ...Read more ›
Find expansion and relocation coverage of Austrian businesses here.
As the global financial system continues to mend, venture capital is beginning to flow back into the biotechnology sector. In Europe, the largest biomed players are thriving, while entrepreneurial biotech start-ups gain traction in the U.S. From the March/April 2013 issue. ...Read more ›